Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide.

Journal of clinical gastroenterology - 1 Aug 2010

Rossignol Jean-Francois, Elfert Asem, Keeffe Emmet B

Abstract excerpt

GOALS: The primary aim of this study was to further evaluate the efficacy of peginterferon plus nitazoxanide without ribavirin using a 4-week lead-in. BACKGROUND: The initial treatment of chronic hepatitis C with nitazoxanide used 12 weeks of nitazoxanide monotherapy before combination therapy wi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Administration Schedule
Share to Interferon-alpha
Share to Interferon alpha-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nitro Compounds

Share to Pilot Projects

Share to Polyethylene Glycols

Share to Ribavirin

Share to Thiazoles

Source

Identifiers

PMID: 20048684
DOI: 10.1097/MCG.0b013e3181bf9b15

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20048684-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide.PMID 20048684Read ↗

Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.Semantic proximity Read ↗

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.Semantic proximity Read ↗

A controlled study of nitazoxanide (NTZ) 3 years after treatment of hepatitis C genotype 4.Semantic proximity Read ↗

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.Semantic proximity Read ↗

Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?Semantic proximity Read ↗

Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment.Semantic proximity Read ↗

Interferons in the management of viral hepatitis.Semantic proximity Read ↗

Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.